Sign In / Join

close

Conferences

Our Conferences articles contain the latest coverage of medical advancements from recent academic conferences.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma

December 18, 2024

Learn how newly diagnosed myeloma patients felt their quality of life was impacted both on and off regimens with elotuzumab.

Breaking Potential New Standard of Care for Relapsed/Refractory Follicular Lymphoma Patients

December 17, 2024

Discover how adding tafasitamab to lenalidomide + rituximab improves outcomes for relapsed/refractory follicular lymphoma patients.

A Fixed-Duration Regimen for CLL: Acalabrutinib + Venetoclax Results from the AMPLIFY Trial

December 17, 2024

Discover how the AMPLIFY trial offers promising new fixed-duration treatment options for patients with newly diagnosed CLL.

Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy

December 17, 2024

ASH 2024: bendamustine lymphodepletion before CAR T-cell therapy in aggressive lymphomas leads to fewer side effects while maintaining survival benefits.

What Can Be Done to Predict Optimal CAR-T Responses?

December 17, 2024

Learn how previous therapies, including BCMA-directed treatment and stem cell transplants, can affect CAR T cell therapy outcomes in multiple myeloma.

Does 24-Hour Urine Testing Add Value to Myeloma Response Results?

December 16, 2024

Learn about the study presented in ASH 2024 that explored the idea of urine-free clinical trial response assessments in multiple myeloma.

New Leukemia Treatment Breakthrough: Adding Blinatumomab Significantly Improves Outcomes for Children

December 16, 2024

Adding blinatumomab to standard therapy reduces relapse risk by 61% in children with B-ALL, marking a significant advance in pediatric leukemia treatment.

U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants

December 13, 2024

New research at ASH 2024 reveals how social & economic factors limit access to stem cell transplants for AML patients, stressing the need for healthcare equity.

The Best of ASH 2024

December 10, 2024

Discover the board's selection of best abstracts at the 66th annual ASH conference.

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

December 10, 2024

Read research highlights from the ASH 2024 conference how certain lifestyle choices affect blood cancers.

Trending Articles

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Tax ID 45-5354811

Conferences

Recent Articles

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma

Breaking Potential New Standard of Care for Relapsed/Refractory Follicular Lymphoma Patients

A Fixed-Duration Regimen for CLL: Acalabrutinib + Venetoclax Results from the AMPLIFY Trial

Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy

What Can Be Done to Predict Optimal CAR-T Responses?

Does 24-Hour Urine Testing Add Value to Myeloma Response Results?

New Leukemia Treatment Breakthrough: Adding Blinatumomab Significantly Improves Outcomes for Children

U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants

The Best of ASH 2024

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Trending Articles

What is Pancytopenia? Symptoms, Causes, & Treatments

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

The Future of Blood Cancer: Advances in Detection, Treatment, and Research

What are Clinical Trials, and How May They Help Me?

What Research is Being Discussed for DLBCL at ASH 2024?

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Conferences

Recent Articles

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma

Breaking Potential New Standard of Care for Relapsed/Refractory Follicular Lymphoma Patients

A Fixed-Duration Regimen for CLL: Acalabrutinib + Venetoclax Results from the AMPLIFY Trial

Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy

What Can Be Done to Predict Optimal CAR-T Responses?

Does 24-Hour Urine Testing Add Value to Myeloma Response Results?

New Leukemia Treatment Breakthrough: Adding Blinatumomab Significantly Improves Outcomes for Children

U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants

The Best of ASH 2024

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Trending Articles

What is Pancytopenia? Symptoms, Causes, & Treatments

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

The Future of Blood Cancer: Advances in Detection, Treatment, and Research

What are Clinical Trials, and How May They Help Me?

What Research is Being Discussed for DLBCL at ASH 2024?

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info